CD Genomics Unveils Revolution in Genomic Research with ddRAD-seq Service

CD Genomics, a leader in the next generation sequencing, is thrilled to announce the availability of its comprehensive ddRAD-seq service. This state-of-the-art service is designed to provide accurate and reliable genotyping by sequencing (GBS), which aids in genetic mapping, identifying novel genes, and dissecting complex genetic traits.

ddRAD-seq, also known as double digest Restriction-site Associated DNA Sequencing, is a next generation genotyping technology that enables researchers to study genetic variations with unprecedented precision. Unlike traditional genotyping methods, which can be time-consuming and expensive, ddRAD-seq is comparatively faster and cost-effective, allowing genomic researchers to streamline their workflows without compromising on the quality or accuracy of data.

"As the pace of genomic research accelerates, there is a pressing need for more efficient and effective genotyping methods," says the Chief Scientist at CD Genomics. "With ddRAD-seq, we can target specific genomic regions of interest using restriction enzymes. This eliminates the need for genome-wide sequencing and thus significantly reduces the cost and time needed for genotyping."

To ensure the highest quality data, CD Genomics has optimized the ddRAD-seq protocol to minimize size bias during DNA fragmentation and to ensure even representation of genomic regions. Additionally, the company's rigorous QC standards and bioinformatics analysis provide clients with high-quality, ready-to-use data.

The ddRAD-seq service complements CD Genomics' existing portfolio of genomic services, including whole genome SNP genotyping, which provides high-resolution detection of genome-wide SNPs. With the introduction of ddRAD-seq, CD Genomics is aiming to revolutionize the way genetic research is conducted, enabling faster, more accurate studies that can provide invaluable insights for a range of applications, from improving crop species to advancing medical research.

Scientists can rely on ddRAD-Seq for identifying genetic variations, particularly single nucleotide polymorphisms (SNPs), the determinants of biodiversity, and keys to unmask the genetic bases of distinct biological traits and species evolution. With assistance from CD Genomics’ ddRAD-Seq services, researchers can conduct whole-genome SNP genotyping, an innovative method that permits the comprehensive assessment of the entire genome's SNPs, hugely amplifying the potential to uncover hidden genetic secrets.

In line with their commitment to provide high-quality, customized genomic sequencing services, CD Genomics' team ensures that they offer tailored solutions for each unique project. CD Genomics takes pride in its comprehensive services, which include stringent quality checks, in-depth data analysis, and professional bioinformatic consultation, thereby aiding scientists in extracting maximum value from their data.

With the introduction of ddRAD-Seq services, CD Genomics continues to revolutionize the field of genomics, providing high-resolution genetic data and furthering the pool of genomic information. By empowering researchers with such cutting-edge technology, CD Genomics is reinforcing its commitment to fueling groundbreaking research in genomics and contributing significantly toward scientific advancements in health, agriculture, and overall biological understanding.

About CD Genomics

CD Genomics stands as a premier provider of sequencing and bioinformatics services. With an unwavering dedication to quality, innovation, and customer satisfaction, CD Genomics serves researchers worldwide as they pursue groundbreaking discoveries.

Contact

Address: Shirley, NY 11967, USA

Email: contact@cd-genomics.com